| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 106,347 | 86,829 | 70,647 | 93,553 | | Cost of Revenue | 96,441 | 73,890 | 58,188 | 81,387 | | | Gross Profit | 9,906 | 12,939 | 12,459 | 12,166 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,822 | 5,535 | 5,300 | 6,162 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,084 | 7,404 | 7,159 | 6,004 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 246 | 366 | 255 | 324 | | Earnings Before Interest And Taxes | 4,330 | 7,770 | 7,414 | 6,607 | | Interest Expense | 268 | 291 | 326 | 425 | | Income Before Tax | 4,062 | 7,479 | 7,088 | 6,182 | | Income Tax Expense | 1,597 | 3,017 | 2,708 | 2,190 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,465 | 4,462 | 4,380 | 3,992 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,465 | 4,462 | 4,380 | 3,992 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,465 | $4,462 | $4,380 | $3,992 |
|
0.03% Nasdaq 
Income Statement
